Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Invest Dermatol. 2017 Oct 17;138(3):557–561. doi: 10.1016/j.jid.2017.09.034

Table 1.

Characteristics of subjects within Research Program on Genes, Environment and Health cohort with at least one incident cSCC by tumor invasiveness (n = 7,667)

Characteristic In Situ Group1 (n = 1,943) Invasive Group2 (n = 5,724) P-Value
Age in years, mean (SD) 71.0 (10.1) 72.6 (9.6) <0.05
Sex, n (%)
 Male 934 (48.1) 3,467 (60.6)
 Female 1,009 (51.9) 2,257 (39.4) <0.05
Immunosuppressed,3 n (%)
 Yes 25 (1.3) 86 (1.5)
 No 1,918 (98.7) 5,638 (98.5) 0.56

Abbreviations: cSCC, cutaneous squamous cell carcinoma; SD, standard deviation.

1

Defined as patients with in situ cSCC only.

2

Defined as patients with at least one invasive SCC.

3

Defined as a history of organ transplantation, chronic lymphocytic, or HIV infection.